Testing Susceptibility of <i>M. tuberculosis</i> to Second Line Anti-Tuberculosis Drugs Using the XDR Test in Clinical Trials and International Professional Testing Cycles

Testing Susceptibility of <i>M. tuberculosis</i> to Second Line Anti-Tuberculosis Drugs Using the XDR Test in Clinical Trials and International Professional Testing Cycles

The objective of the study: to evaluate the commercial XDR test for susceptibility testing of M. tuberculosis to second line anti-tuberculosis drugs in clinical trials and as part of annual professional testing cycles coordinated by the World Health Organization (WHO).Subjects and Methods. Cultures...

Full description

Saved in:
Bibliographic Details
Main Authors: L. V. Domotenko, T. P. Morozova, M. V. Khramov, А. P. Shepelin
Format: Article
Language:Russian
Published: New Terra Publishing House 2021-09-01
Series:Туберкулез и болезни лёгких
Subjects:
<i>m. tuberculosis</i>
drug susceptibility
second line anti-tuberculosis drugs
nitrate reductase method
the xdr test
Online Access:https://www.tibl-journal.com/jour/article/view/1558
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items